Education
About Us
Working with TipRanks
Follow Us
Matinas BioPharma (MTNB)
XASE:MTNB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.10M | $ 3.19M | $ 33.00K | $ 158.33K |
| Gross Profit | $ 0.00 | $ 1.10M | $ -13.49M | $ -14.55M | $ -14.20M |
| Operating Income | $ -24.59M | $ -23.77M | $ -24.59M | $ -24.73M | $ -24.21M |
| EBITDA | $ -19.19M | $ -22.82M | $ -24.23M | $ -24.45M | $ -23.92M |
| Net Income | $ -24.25M | $ -22.94M | $ -21.00M | $ -23.28M | $ -22.45M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.28M | $ 13.76M | $ 28.81M | $ 49.62M | $ 58.68M |
| Total Assets | $ 12.64M | $ 25.10M | $ 78.87M | $ 61.33M | $ 70.97M |
| Total Debt | $ 2.89M | $ 3.56M | $ 4.12M | $ 4.70M | $ 3.75M |
| Net Debt | $ -4.39M | $ -1.23M | $ -2.76M | $ -16.33M | $ -8.68M |
| Total Liabilities | $ 5.05M | $ 5.86M | $ 42.23M | $ 8.83M | $ 7.24M |
| Stockholders' Equity | $ 7.59M | $ 19.25M | $ 36.64M | $ 52.49M | $ 63.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -15.88M | $ -15.50M | $ -20.05M | $ -15.48M | $ -17.37M |
| Operating Cash Flow | $ -15.88M | $ -15.28M | $ -19.16M | $ -15.22M | $ -17.37M |
| Investing Cash Flow | $ 9.21M | $ 13.24M | $ 4.88M | $ 16.77M | $ -40.67M |
| Financing Cash Flow | $ 9.17M | $ -7.00K | $ 79.00K | $ 6.96M | $ 48.05M |